VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.98 Cr | ₹2.49 Cr | ₹2.44 Cr | ₹3.14 Cr | ₹2.82 Cr |
What is the latest Contingent Liabilities ratio of VIMTA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2024 | ₹4.98 Cr |
| Mar2023 | ₹2.49 Cr |
| Mar2022 | ₹2.44 Cr |
| Mar2021 | ₹3.14 Cr |
| Mar2020 | ₹2.82 Cr |
How is Contingent Liabilities of VIMTA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.98 Cr | 100.12 | |
| Mar2023 | ₹2.49 Cr | 1.97 | |
| Mar2022 | ₹2.44 Cr | -22.22 | |
| Mar2021 | ₹3.14 Cr | 11.16 | |
| Mar2020 | ₹2.82 Cr | - | |
Compare Contingent Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,063.4 Cr | 10.2% | 3.7% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 10.2% |
3.7% |
0.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses